reflecting < refractory < refugees

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by refractory

Number of relevant bibliographic references: 30.
[0-20] [0 - 20][0 - 30][20-29][20-40]

Ident.	Authors (with country if any)	Title
000308 (2019)	Xiaoyang Yang [République populaire de Chine] ; Shufang Zhang [République populaire de Chine] ; Denggao Huang [République populaire de Chine] ; Zhiming Wang [République populaire de Chine] ; Xiaoxia Chen [République populaire de Chine] ; Xiansheng Luo [République populaire de Chine] ; Meiqing Lei [République populaire de Chine] ; Feng Yu [République populaire de Chine] ; Xiaobo Chen [République populaire de Chine] ; Peilong Huang [République populaire de Chine]	Treatment of refractory secondary hemophagocytic lymphohistiocytosis with umbilical cord mesenchymal stem cells
000462 (2019)	Peter Korsten ; Gerhard A. Müller ; Jan-Gerd Rademacher ; Michael Zeisberg ; Björn Tampe	Rheopheresis for Digital Ulcers and Raynaud's Phenomenon in Systemic Sclerosis Refractory to Conventional Treatments
000674 (2019)	Chunmiao Zhao [République populaire de Chine] ; Yanfang Chu [République populaire de Chine] ; Zhaoyun Liang [République populaire de Chine] ; Bingying Zhang [République populaire de Chine] ; Xuxia Wang [République populaire de Chine] ; Xiaona Jing [République populaire de Chine] ; Meihua Hao [République populaire de Chine] ; Yiqi Wang [République populaire de Chine] ; Jia An [République populaire de Chine] ; Xingzhe Zhang [République populaire de Chine] ; Liguang Sun [République populaire de Chine] ; Junwei Chen [République populaire de Chine]	Low dose of IL-2 combined with rapamycin restores and maintains the long-term balance of Th17/Treg cells in refractory SLE patients
000A01 (2019)	Anjali Patwardhan [États-Unis] ; Charles H. Spencer [États-Unis]	Biologics in refractory myositis: experience in juvenile vs. adult myositis; part II: emerging biologic and other therapies on the horizon
000B77 (2019)	Asim Khan ; Ghazal Ansari ; Hoda Al-Koky ; Arti Mahto ; Hasan Tahir	25. Use of rituximab in refractory primary antiphospholipid syndrome with pulmonary and cerebral manifestations
000C15 (2018)	Fevzi F. Yalniz [États-Unis] ; Mohammad H. Murad [États-Unis] ; Stephanie J. Lee [États-Unis] ; Steven Z. Pavletic [États-Unis] ; Nandita Khera [États-Unis] ; Nilay D. Shah [États-Unis] ; Shahrukh K. Hashmi [Arabie saoudite]	Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis.
000C40 (2018)	Cécile Rotenberg [France] ; Valérie Besnard [France] ; Pierre-Yves Brillet [France] ; Stéphane Giraudier [France] ; Hilario Nunes [France] ; Dominique Valeyre [France]	Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia.
000D06 (2017)	Magdalena Circu [États-Unis] ; James Cardelli [États-Unis] ; Martin P. Barr [Irlande (pays)] ; Kenneth O'Byrne [Australie] ; Glenn Mills [États-Unis] ; Hazem El-Osta [États-Unis]	Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.
000D42 (2016-04)	François Chasset [France] ; Laurent Arnaud [France] ; Nathalie Costedoat-Chalumeau [France] ; Noël Zahr [France] ; Didier Bessis [France] ; Camille Francès [France]	The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study
000F05 (2015)	Kwan-Hwa Chi [Taïwan] ; Hui-Ling Ko [Taïwan] ; Kai-Lin Yang [Taïwan] ; Cheng-Yen Lee [Taïwan] ; Mau-Shin Chi [Taïwan] ; Shang-Jyh Kao [Taïwan]	Addition of rapamycin and hydroxychloroquine to metronomic chemotherapy as a second line treatment results in high salvage rates for refractory metastatic solid tumors: a pilot safety and effectiveness analysis in a small patient cohort.
001114 (2013)	Eric Russell [États-Unis] ; Francis Luk ; Sonia Manocha ; Tung Ho ; Carolyn O'Connor ; Humaira Hussain	Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.
001153 (2013)	I. Pérez-Martín ; R. Blanco ; N. Ortego ; V. Llorens-Bellés [Espagne] ; A. Adán [Espagne] ; A. Olivé ; W. A. Sifuentes Giraldo [Espagne] ; S. González [Espagne] ; C. Bejerano ; M. C. González-Vela ; M. A. González-L Pez ; H. Fernández-Llaca ; A. Oterino ; M. J. Sedano ; M. Agudo ; A. Corrales ; V. M. Martínez-Taboada ; M. A. G Nzalez-Gay	THU0391 Anti-TNF therapy in severe and refractory sarcoidosis: Multicenter study of 25 patients
001174 (2013)	Linda Nalotto [Italie] ; Luca Iaccarino [Italie] ; Margherita Zen [Italie] ; Mariele Gatto [Italie] ; Elisabetta Borella [Italie] ; Marta Domenighetti [Italie] ; Leonardo Punzi [Italie] ; Andrea Doria [Italie]	Rituximab in refractory idiopathic inflammatory myopathies and antisynthetase syndrome: personal experience and review of the literature
001244 (2013)	Duygu Emine Ersozlu Bozkirli [Turquie] ; Ilknur Kozanoglu [Turquie] ; Emre Bozkirli [Turquie] ; Eftal Yucel [Turquie]	Antisynthetase syndrome with refractory lung involvement and myositis successfully treated with double filtration plasmapheresis
001326 (2012)	H. Ahmadzai ; M. C. Kiernan ; D. Wakefield [Australie] ; P. S. Thomas	Treatment of refractory neurosarcoidosis with TNF‐inhibitors: what lies ahead?
001346 (2012)	Yolanda Braun-Moscovici [Israël] ; Yonatan Butbul-Aviel [Israël] ; Ludmila Guralnik [Israël] ; Kochava Toledano [Israël] ; Doron Markovits [Israël] ; Alexander Rozin [Israël] ; Menahem A. Nahir [Israël] ; Alexandra Balbir-Gurman [Israël]	Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience
001351 (2012)	Abdulkadir Unsal [Turquie] ; Taner Basturk [Turquie] ; Yener Koc [Turquie] ; Tamer Sakac [Turquie] ; Elbis Ahbap [Turquie] ; Aysim Ozagar [Turquie] ; Ay E Sinangil Arar [Turquie] ; Cüneyt Akgül [Turquie] ; Mustafa Sev Nc [Turquie]	Renal sarcoidosis with normal serum vitamin D and refractory hypercalcemia
001353 (2012)	Adam P. Croft [Royaume-Uni] ; Deva Situnayake [Royaume-Uni] ; Omer Khair [Royaume-Uni] ; Gavin Giovanni [Royaume-Uni] ; David Carruthers [Royaume-Uni] ; Arul Sivaguru [Royaume-Uni] ; Caroline Gordon [Royaume-Uni]	Refractory multisystem sarcoidosis responding to infliximab therapy
001549 (2011)	Nadia Emi Aikawa [Brésil] ; Ana Cristina De Medeiros Ribeiro [Brésil] ; Carla Gonçalves Schain Saad [Brésil] ; Rosa Maria Rodrigues Pereira [Brésil] ; Mauricio Levy [Brésil] ; Clovis A. Silva [Brésil] ; Eloísa Bonfá [Brésil] ; Jozélio Freire De Carvalho [Brésil]	Is anti-TNF switching in refractory Still’s disease safe and effective?
001665 (2010)	Martin A. Lee [Royaume-Uni] ; David G. Hutchinson [Royaume-Uni]	Spontaneous pneumomediastinum secondary to refractory dermatomyositis successfully treated with rituximab
001A08 (2008)	A. Delluc [France] ; N. Limal [France] ; X. Puéchal [France] ; C. Francès [France] ; J C Piette [France] ; P. Cacoub [France]	Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "refractory" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "refractory" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    refractory
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021